Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc. (SPPI) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
sppi · stock forecast · 14 analysts (3M) · FMP · updated Mar 26, 2024
Analyst Rating & Consensus
Based on 14 Wall Street analysts in the past 3 months
Hold
14 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.75
Consensus
$0.75
-27.2% upside
Low
$0.75
Median: $0.75 · Last Close: $1.03
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.04 | ↑ 1.30% |
1-day model range: $1.04–$1.05. Peak: $1.05 (+1.30%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -50.0% |
| 2028 | $0 | -62.5% |
| 2029 | $0 | -67.2% |
| 2030 | $0 | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SPPI · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-05-26 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2023-05-26 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2023-05-25 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2023-05-15 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2023-05-14 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2023-04-26 | JMP Securities | Downgrade ↓ | Market Outperform→Perform |
| 2023-04-26 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2023-04-25 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2023-04-25 | JMP Securities | Downgrade ↓ | Market Outperform→Perform |
| 2023-02-06 | JMP Securities | Maintains | Market Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Spectrum Pharmaceuticals, Inc. (SPPI) stock. Of the recent 67 rating actions, 2 were upgrades and 16 were downgrades. 14 analysts currently cover SPPI.
Analyst Recommendation Trends
SPPI analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 6 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
—
Revenue Next Year
—
EPS This Year
—
EPS Next Year
—
EPS ForecastReported vs Estimated
Analysts forecast SPPI EPS of $— for the current fiscal year, based on estimates from 0 analysts. The SPPI revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The SPPI stock forecast is supported by two independent data sources: analyst consensus ratings from 14 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SPPI price target is $0.75 (-27.2% upside), with an analyst consensus of Hold.
The SPPI short-term stock prediction for tomorrow is $1.04 (+1.30%). The SPPI stock price prediction for 2027 estimates an average of $1. The SPPI stock prediction for 2030 projects a range of $0–$0.
Spectrum Pharmaceuticals, Inc. trades on NASDAQ under the ticker SPPI. The SPPI stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 43% of covering analysts.
Frequently asked questions
SPPI forecast · 8 questionsAccording to 14 Wall Street analysts, the average 12-month SPPI price target is $0.75, with a high forecast of $0.75 and a low of $0.75. The median price target is shown in the chart above when available. This implies -27.2% potential upside from the current price of $1.03.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.